316 related articles for article (PubMed ID: 10625193)
1. First-episode schizophrenia: the importance of early intervention and subjective tolerability.
Kasper S
J Clin Psychiatry; 1999; 60 Suppl 23():5-9. PubMed ID: 10625193
[TBL] [Abstract][Full Text] [Related]
2. Partial response to antipsychotic treatment: the patient with enduring symptoms.
Emsley RA
J Clin Psychiatry; 1999; 60 Suppl 23():10-3. PubMed ID: 10625194
[TBL] [Abstract][Full Text] [Related]
3. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
Gerlach J
J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia.
Nasrallah HA; Tandon R
J Clin Psychiatry; 2002; 63 Suppl 13():12-20. PubMed ID: 12562142
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine has a direct effect on the negative symptoms of schizophrenia.
Tandon R
Hum Psychopharmacol; 2004 Dec; 19(8):559-63. PubMed ID: 15486960
[TBL] [Abstract][Full Text] [Related]
6. The older patient: the ongoing challenge of efficacy and tolerability.
Tariot PN
J Clin Psychiatry; 1999; 60 Suppl 23():29-33. PubMed ID: 10625198
[TBL] [Abstract][Full Text] [Related]
7. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
Perez V; Cañas F; Tafalla M;
Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
[TBL] [Abstract][Full Text] [Related]
8. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms.
Taniguchi T; Sumitani S; Aono M; Iga J; Kinouchi S; Aki H; Matsushita M; Taniguchi K; Tsuno M; Yamanishi K; Tomotake M; Kaneda Y; Ohmori T
Hum Psychopharmacol; 2006 Oct; 21(7):439-45. PubMed ID: 17029303
[TBL] [Abstract][Full Text] [Related]
9. Treatment-resistant schizophrenia: reviewing the options and identifying the way forward.
Hellewell JS
J Clin Psychiatry; 1999; 60 Suppl 23():14-9. PubMed ID: 10625195
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Buckley PF
Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients.
Høiberg MP; Nielsen B
Nord J Psychiatry; 2006; 60(3):207-12. PubMed ID: 16720511
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
Lee KU; Jeon YW; Lee HK; Jun TY
Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
[TBL] [Abstract][Full Text] [Related]
13. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
Kopala LC; Fredrikson D; Good KP; Honer WG
Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
[No Abstract] [Full Text] [Related]
14. Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia.
Kasper S
Depress Anxiety; 2004; 20(1):44-7. PubMed ID: 15368596
[TBL] [Abstract][Full Text] [Related]
15. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of schizophrenia].
Houy-Durand E; Thibaut F
Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
[TBL] [Abstract][Full Text] [Related]
19. Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: a case series.
Pajonk FG; Schwertner AK; Seelig MA
J Psychopharmacol; 2006 Jan; 20(1):119-24. PubMed ID: 16204326
[TBL] [Abstract][Full Text] [Related]
20. ICI 204,636: a new atypical antipsychotic drug.
Hirsch SR; Link CG; Goldstein JM; Arvanitis LA
Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
